A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition: Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions: Drug: Bedaquiline; Drug: Clarithromycin; Drug: Ethambutol; Drug: Rifampicin; Drug: Rifabutin Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials